Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Gynecologic 1Breast 1

Conditions

Sedentary Behavior 2Obesity 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Blood Glucose Self-Monitoring × Clear all
NCT05409664 2025-05-15

MFT4

University of South Carolina

Phase NA Active not recruiting
68 enrolled
Breast

Breast Neoplasms, Sedentary Behavior

NCT05737745 2025-05-09

FitEx for Endometrial Cancer Survivors: Initial Efficacy

Carilion Clinic

Phase NA Completed
111 enrolled 7 charts
GynecologicOther

Obesity, Endometrial Neoplasms, Sedentary Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡